Solid Biosciences Inc.
SLDB
$9.54
-$0.39-3.93%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 13.12M | 11.17M | 11.27M | 9.20M | 9.28M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 57.38M | 57.31M | 49.40M | 48.06M | 41.69M |
| Operating Income | -57.38M | -57.31M | -49.40M | -48.06M | -41.69M |
| Income Before Tax | -54.80M | -56.74M | -49.79M | -45.78M | -39.48M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -54.80M | -56.74M | -49.79M | -45.78M | -39.48M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -54.80M | -56.74M | -49.79M | -45.78M | -39.48M |
| EBIT | -57.38M | -57.31M | -49.40M | -48.06M | -41.69M |
| EBITDA | -56.99M | -56.91M | -48.94M | -47.68M | -41.31M |
| EPS Basic | -0.38 | -0.52 | -0.53 | -0.48 | -0.42 |
| Normalized Basic EPS | -0.24 | -0.32 | -0.33 | -0.30 | -0.26 |
| EPS Diluted | -0.38 | -0.52 | -0.53 | -0.48 | -0.42 |
| Normalized Diluted EPS | -0.24 | -0.32 | -0.33 | -0.30 | -0.26 |
| Average Basic Shares Outstanding | 143.69M | 109.81M | 94.73M | 94.42M | 94.14M |
| Average Diluted Shares Outstanding | 143.69M | 109.81M | 94.73M | 94.42M | 94.14M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |